Key result
Primary angiosarcoma of the spleen is an extremely rare and aggressive neoplasm with a dismal prognosis, presenting most commonly with abdominal pain and carrying an overall survival of up to 12 months.
Why the study?
Primary angiosarcoma of the spleen is an extremely rare, aggressive neoplasm with poor prognosis that is frequently forgotten and challenging to diagnose early.
Primary angiosarcoma of the spleen is a rare, aggressive neoplasm with a dismal prognosis of up to 12 months survival, requiring a high index of suspicion for early diagnosis and multidisciplinary management.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare splenic angiosarcoma with poor prognosis; leaves open evidence-based management strategies.
Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angiosarcoma is one of the extremely rare malignant vascular neoplasms of the spleen, which carries a dismal prognosis. It constitutes almost 7.4% of all primary malignant splenic neoplasms and is well known as an aggressive tumor with high local recurrence and distant metastasis rates. Overall survival is up to 12 months following diagnosis, regardless of management strategy. Due to the broad differential diagnosis of splenic tumors, this tumor is often forgotten, and is very challenging to diagnose early. Less than 300 cases of primary splenic angiosarcoma have been reported in the English literature. The main issue of this article is to review the current English literature to figure out the characteristic demographic features, clinical presentation, imaging findings and management of such tumors, in order to increase awareness of the treating physicians to improve diagnosis, management, as well as overall survival.
No takes yet. Share an insight, caveat, or question.
Damouny et al. (2022) conducted a review in Primary angiosarcoma of the spleen (n=300). Primary splenic angiosarcoma was evaluated on Overall survival. Primary angiosarcoma of the spleen is an extremely rare and aggressive neoplasm with a dismal prognosis, presenting most commonly with abdominal pain and carrying an overall survival of up to 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: